Class II
Ongoing
Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-487-52
This recall is currently active, issued May 3, 2023. It was issued by Northwind Pharmaceuticals Llc.
- Company
- Northwind Pharmaceuticals Llc
- Recall Initiated
- March 16, 2023
- Posted
- May 3, 2023
- Recall Number
- D-0554-2023
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 23 bottles
- Firm Location
- Indianapolis, IN, United States
- Official Source
- View on FDA website ↗
Reason for Recall
CGMP Deviations
Distribution
Nationwide with the United States
Lot / Code Info
Lot #: F114302001, Exp. Date 05/31/2023
More recalls by Northwind Pharmaceuticals Llc
Sulfamethoxazole and Trimethoprim Tablets, USP 800mg / 160mg Double Strength packaged in a) 6-count...
Sep 24, 2025 · Class II
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026